Hostname: page-component-cd9895bd7-dzt6s Total loading time: 0 Render date: 2025-01-01T01:04:22.516Z Has data issue: false hasContentIssue false
  • English
  • Français

Epidemiological Model for Clostridium difficile Transmission in Healthcare Settings

Published online by Cambridge University Press:  02 January 2015

C. Lanzas ,
E. R. Dubberke ,
Z. Lu ,
K. A. Reske  and
Y. T. Gröhn
C. Lanzas
Affiliation:
Department of Population Medicine and Diagnostic Sciences, College of Veterinary Medicine, Cornell University, Ithaca, New York Department of Comparative Medicine, College of Veterinary Medicine, University of Tennessee, Knoxville, Tennessee
E. R. Dubberke
Affiliation:
Department of Medicine, Washington University School of Medicine, St. Louis, Missouri
Z. Lu
Affiliation:
Department of Population Medicine and Diagnostic Sciences, College of Veterinary Medicine, Cornell University, Ithaca, New York
K. A. Reske
Affiliation:
Department of Medicine, Washington University School of Medicine, St. Louis, Missouri
Y. T. Gröhn
Affiliation:
Department of Population Medicine and Diagnostic Sciences, College of Veterinary Medicine, Cornell University, Ithaca, New York
Get access Rights & Permissions [Opens in a new window]

Abstract

Objective.

Recent outbreaks of Clostridium difficile infection (CDI) have been difficult to control, and data indicate that the importance of different sources of transmission may have changed. Our objectives were to evaluate the contributions of asymptomatic and symptomatic C. difficile carriers to new colonizations and to determine the most important epidemiological factors influencing C. difficile transmission.

Design, Setting, and Patients.

Retrospective cohort study of all patients admitted to medical wards at a large tertiary care hospital in the United States in the calendar year 2008.

Methods.

Data from six medical wards and published literature were used to develop a compartmental model of C. difficile transmission. Patients could be in one of five transition states in the model: resistant to colonization (R), susceptible to colonization (S), asymptomatically colonized without protection against CDI (C-), asymptomatically colonized with protection against CDI (C+), and diseased (ie, with CDI; D).

Results.

The contributions of C-, C+, and D patients to new colonizations were similar. The simulated basic reproduction number ranged from 0.55 to 1.99, with a median of 1.04. These values suggest that transmission within the ward alone from patients with CDI cannot sustain new C. difficile colonizations and therefore that the admission of colonized patients plays an important role in sustaining transmission in the ward. The epidemiological parameters that ranked as the most influential were the proportion of admitted C- patients and the transmission coefficient for asymptomatic carriers.

Conclusion.

Our study underscores the need to further evaluate the role of asymptomatically colonized patients in C. difficile transmission in healthcare settings.

Type
Original Articles
Information
Infection Control & Hospital Epidemiology , Volume 32 , Issue 6 , June 2011 , pp. 553 - 561
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2011

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Miller, BA, Chen, LF, Sexton, DJ, Anderson, DJ. The impact of hospital-onset healthcare facility associated (HO-HCFA) Clostridium difficile infection (CDI) in community hospitals: surpassing methicillin-resistant Staphylococcus aureus (MRSA) as the new superbug. Paper presented at: 5th Decennial International Conference on Healthcare-Associated Infections, 18-22 March 2010; Atlanta, Georgia.Google Scholar
2.McDonald, LC, Killgore, GE, Thompson, A, et al.An epidemic, toxin gene-variant strain of Clostridium difficile. N Engl J Med 2005;353(23):2433–2441.Google Scholar
3.O'Brien, JA, Lahue, BJ, Caro, JJ, Davidson, DM. The emerging infectious challenge of Clostridium difficile-associated disease in Massachusetts hospitals: clinical and economic consequences. Infect Control Hosp Epidemiol 2007;28(11):1219–1227.Google Scholar
4.Dubberke, ER, Butler, AM, Reske, KA, et al.Attributable outcomes of endemic Clostridium difficile-associated disease in nonsurgical patients. Emerg Infect Dis 2008;14(7):103l–1038.CrossRefGoogle ScholarPubMed
5.McDonald, LC, Owings, M, Jernigan, DB. Clostridium difficile infection in patients discharged from US short-stay hospitals, 1996-2003. Emerg Infect Dis 2006;12(3):409–415.Google Scholar
6.Valiquette, L, Cossette, B, Garant, MP, Diab, H, Pépin, J. Impact of a reduction in the use of high-risk antibiotics on the course of an epidemic of Clostridium difficile-associated disease caused by the hypervirulent NAP1/027 strain. Clin Infect Dis 2007;45(suppl 2):S112–S121.Google Scholar
7.McFarland, LV, Mulligan, ME, Kwok, RY, Stamm, WE. Nosocomial acquisition of Clostridium difficile infection. N Engl J Med 1989;320(4):204–210.Google Scholar
8.Samore, MH, Venkataraman, L, DeGirolami, PC, Arbeit, RD, Karchmer, AW. Clinical and molecular epidemiology of sporadic and clustered cases of nosocomial Clostridium difficile diarrhea. Am J Med 1996;100(1):32–40.Google Scholar
9.Clabots, CR, Johnson, S, Olson, MM, Peterson, LR, Gerding, DN. Acquisition of Clostridium difficile by hospitalized patients: evidence for colonized new admissions as a source of infection. J Infect Dis 1992;166(3):561–567.CrossRefGoogle ScholarPubMed
10.Dubberke, ER, Gerding, DN, Classen, D, et al.Strategies to prevent Clostridium difficile infections in acute care hospitals. Infect Control Hosp Epidemiol 2008;29(suppl 1):S81–S92.Google Scholar
11.McFarland, LV, Beneda, HW, Clarridge, JE, Raugi, GJ. Implications of the changing face of Clostridium difficile disease for health care practitioners. Am J Infect Control 2007;35(4):237–253.Google Scholar
12.Boyce, JM, Pittet, D. Guideline for hand hygiene in health-care settings: recommendations of the Healthcare Infection Control Practices Advisory Committee and the HICPAC/SHEA/APIC/IDSA Hand Hygiene Task Force (Society for Healthcare Epidemiology of America/Association for Professionals in Infection Control/Infectious Diseases Society of America). MMWR Morb Mortal Wkly Rep 2002;51(RR16):145, quiz CE4144.Google ScholarPubMed
13.Oughton, MT, Loo, VG, Dendukuri, N, Fenn, S, Libman, MD. Hand hygiene with soap and water is superior to alcohol rub and antiseptic wipes for removal of Clostridium difficile. Infect Control Hosp Epidemiol 2009;30(10):939–944.CrossRefGoogle ScholarPubMed
14.Abbett, SK, Yokoe, DS, Lipsitz, SR, et al.Proposed checklist of hospital interventions to decrease the incidence of healthcare-associated Clostridium difficile infection. Infect Control Hosp Epidemiol 2009;30(11):1062–1069.Google Scholar
15.Austin, DJ, Bonten, MJM, Weinstein, RA, Slaughter, S, Anderson, RM. Vancomycin-resistant enterococci in intensive-care hospital settings: transmission dynamics, persistence, and the impact of infection control programs. Proc Natl Acad Sci USA 1999;96(12): 6908–6913.Google Scholar
16.D'Agata, EMC, Webb, G, Horn, M. A mathematical model quantifying the impact of antibiotic exposure and other interventions ori the endemic prevalence of vancpmycin-resistant enterococci. J Infect Dis 2005;192(11):2004–2011.Google Scholar
17.Bootsma, MCJ, Diekmann, O, Bonten, MJM. Controlling methi-cillin-resistant Staphylococcus aureus: quantifying the effects of interventions and rapid diagnostic testing. Proc Natl Acad Sci USA 2006;103(14):5620–5625.Google Scholar
18.Starr, JM, Campbell, A, Renshaw, E, Poxton, IR, Gibson, GJ. Spatio-temporal stochastic modelling of Clostridium difficile. J Hosp Infect 2009;71(1):49–56.CrossRefGoogle ScholarPubMed
19.McCoubrey, J, Starr, J, Martin, H, Poxton, IR. Clostridium difficile in a geriatric unit: a prospective epidemiological study employing a novel S-layer typing method. J Med Microbiol 2003;52(7): 573–578.CrossRefGoogle Scholar
20.Johnson, S, Gerding, DN. Clostridium difficile-associated diarrhea. Clin Infect Dis 1998;26(5):1027–1034.Google Scholar
21.Johnson, S, Homann, SR, Bettin, KM, et al.Treatment of asymptomatic Clostridium difficile carriers (fecal excretors) with vancomycin or metronidazole: a randomized, placebo-controlled trial. Ann Intern Med 1992;117(4):297–302.Google Scholar
22.Rafii, F, Sutherland, JB, Cerniglia, CE. Effects of treatment with antimicrobial agents on the human colonic rnicroflora. Ther Clin Risk Manag 2008;4(6):1343–1358.CrossRefGoogle Scholar
23.Kyne, L, Warny, M, Qamar, A, Kelly, CP. Asymptomatic carriage of Clostridium difficile and serum levels of IgG antibody against Toxin A. N Engl J Med 2000;342(6):390–397.CrossRefGoogle ScholarPubMed
24.McFarland, LV. Update on the changing epidemiology of Clostridium difficile-associated disease. Nat Clin Pract Gastroenterol Hepatol 2008;5(1):40–48.CrossRefGoogle ScholarPubMed
25.Chang, HT, Krezolek, D, Johnson, S, Parada, JP, Evans, CT, Gerding, DN. Onset of symptoms and time to diagnosis of Clostridium difficile-associated disease following discharge from an acute care hospital. Infect Control Hosp Epidemiol 2007;28(8):926–931.CrossRefGoogle ScholarPubMed
26.Diekmann, O, Heesterbeek, JAP. Mathematical epidemiology of infectious diseases: model building, analysis and interpretation. Chichester: Wiley, 2000.Google Scholar
27.Sobol', IM. Global sensitivity indices for nonlinear mathematical models and their Monte Carlo estimates. Math Comput Simul 2001;55(1-3):271–280.Google Scholar
28.Otten, AM, Reid-Smith, RJ, Fazil, A, Weese, JS. Disease transmission model for community-associated Clostridium difficile infection. Epidemiol Infect 2010;138(6):907–914.Google Scholar
29.Kuijper, EJ, Coignard, B, Tüll, P. Emergence of Clostridium difficile-associated disease in North America and Europe. Clin Microbiol Infect 2006;12(suppl s6):2–18.Google Scholar
30.Dubberke, ER. The A, B, BI, and Cs of Clostridium difficile. Clin Infect Dis 2009;49(8):1148–1152.Google Scholar
31.Wilcox, MH, Mooney, L, Bendall, R, Settle, CD, Fawley, WN. A case-control study of community-associated Clostridium difficile infection. J Antimicrob Chemother 2008;62(2):388–396.CrossRefGoogle ScholarPubMed
32.Weese, JS. Clostridium difficile in food: innocent bystander or serious threat? Clin Microbiol Infect 2010;16(1):3–10.Google Scholar
33.Dubberke, ER, McMullen, KM, Mayfield, JL, et al.Hospital-associated Clostridium difficile infection: is it necessary to track community-onset disease? Infect Control Hosp Epidemiol 2009;30(4):332–337.Google Scholar
34.Kyne, L, Sougioultzis, S, McFarland, LV, Kelly, CP. Underlying disease severity as a major risk factor for nosocomial Clostridium difficile diarrhea. Infect Control Hosp Epidemiol 2002;23(11):653–659.Google Scholar
35.Johnson, S, Gerding, DN, Olson, MM, et al.Prospective, controlled study of vinyl glove use to interrupt Clostridium difficile nosocomial transmission. Am J Med 1990;88(2):137–140.Google Scholar
36.Cohen, SH, Gerding, DN, Johnson, S, et al.Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA). Infect Control Hosp Epidemiol 2010;31(5):431–55.Google Scholar
37.Litvin, M, Reske, KA, Mayfield, J, et al.Identification of a pseudo-outbreak of Clostridium difficile infection (CDI) and the effect of repeated testing, sensitivity, and specificity on perceived prevalence of CDI. Infect Control Hosp Epidemiol 2009;30(12):1166–1171.Google Scholar
38.Dubberke, ER. Prevention of healthcare-associated Clostridium difficile infection: what works? Infect Control Hosp Epidemiol 2010;31(suppl 1):S38–S41.Google Scholar
39.Keeling, MJ, Rohani, P. Modeling infectious diseases in humans and animals. Princeton, NJ: Princeton University Press, 2008.Google Scholar